• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向癌症的瓦博格效应实现肿瘤特异性药物递送。

Enabling tumor-specific drug delivery by targeting the Warburg effect of cancer.

作者信息

Zhang Jian, Pan Tony, Lee Jimmy, Goldberg Sanja, King Sarah Ann, Tang Erting, Hu Yifei, Chen Lifeng, Hoover Alex, Zhu Linyong, Eng Oliver S, Dekel Benjamin, Huang Jun, Wu Xiaoyang

机构信息

Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA; Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.

Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Cell Rep Med. 2025 Jan 21;6(1):101920. doi: 10.1016/j.xcrm.2024.101920. Epub 2025 Jan 13.

DOI:10.1016/j.xcrm.2024.101920
PMID:39809265
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11866520/
Abstract

Metabolic reprogramming of tumor cells is an emerging hallmark of cancer. Among all the changes in cancer metabolism, increased glucose uptake and the accumulation of lactate under normoxic conditions (the "Warburg effect") is a common feature of cancer cells. In this study, we develop a lactate-responsive drug delivery platform by targeting the Warburg effect. We design and test a gold/mesoporous silica Janus nanoparticle system as a gated drug carrier, in which the gold particles are functionalized with lactate oxidase and the silica particles are capped with α-cyclodextrin through surface arylboronate modification. In the presence of lactate, the lactate oxidase generates hydrogen peroxide, which induces the self-immolation reaction of arylboronate, leading to uncapping and drug release. Our results demonstrate greatly improved drug delivery specificity and therapeutic efficacy with this platform for the treatment of different cancers. Our findings present an effective approach for drug delivery by metabolic targeting of tumors.

摘要

肿瘤细胞的代谢重编程是癌症一个新出现的标志。在癌症代谢的所有变化中,在常氧条件下葡萄糖摄取增加和乳酸积累(“瓦伯格效应”)是癌细胞的一个共同特征。在本研究中,我们通过靶向瓦伯格效应开发了一种乳酸响应型药物递送平台。我们设计并测试了一种金/介孔二氧化硅 Janus 纳米颗粒系统作为门控药物载体,其中金颗粒用乳酸氧化酶功能化,二氧化硅颗粒通过表面芳基硼酸酯修饰用α-环糊精封端。在乳酸存在的情况下,乳酸氧化酶产生过氧化氢,过氧化氢诱导芳基硼酸酯的自焚反应,导致封端解除和药物释放。我们的结果表明,该平台在治疗不同癌症时具有大大提高的药物递送特异性和治疗效果。我们的发现为通过肿瘤的代谢靶向进行药物递送提供了一种有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/0d73b9074dc6/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/1f4f017ed62c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/bf5acd99b62a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/1f054cb4b176/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/289ba4d1178d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/b245eee34157/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/29894b5091e5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/f8e91feca56c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/0d73b9074dc6/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/1f4f017ed62c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/bf5acd99b62a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/1f054cb4b176/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/289ba4d1178d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/b245eee34157/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/29894b5091e5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/f8e91feca56c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7891/11866520/0d73b9074dc6/gr7.jpg

相似文献

1
Enabling tumor-specific drug delivery by targeting the Warburg effect of cancer.通过靶向癌症的瓦博格效应实现肿瘤特异性药物递送。
Cell Rep Med. 2025 Jan 21;6(1):101920. doi: 10.1016/j.xcrm.2024.101920. Epub 2025 Jan 13.
2
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.一种双功能 HER2 适体偶联、pH 激活的介孔硅纳米载体药物传递系统,为 HER2 阳性乳腺癌细胞提供体外协同细胞毒性。
Int J Nanomedicine. 2019 May 31;14:4029-4044. doi: 10.2147/IJN.S201688. eCollection 2019.
3
Tailored Covalent Organic Framework Platform: From Multistimuli, Targeted Dual Drug Delivery by Architecturally Engineering to Enhance Photothermal Tumor Therapy.定制共价有机框架平台:通过结构工程实现多刺激、靶向双重药物传递,以增强光热肿瘤治疗。
ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28245-28262. doi: 10.1021/acsami.4c05989. Epub 2024 May 21.
4
Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy.基于二硒键的蛋白门控上转换纳米颗粒嵌入介孔硅纳米载体用于药物释放的实时追踪和肿瘤化疗
ACS Appl Mater Interfaces. 2021 Jun 23;13(24):29070-29082. doi: 10.1021/acsami.1c04447. Epub 2021 Jun 8.
5
Gold nanoparticle-capped mesoporous silica-based HO-responsive controlled release system for Alzheimer's disease treatment.用于阿尔茨海默病治疗的金纳米颗粒包覆的介孔二氧化硅基过氧化氢响应型控释系统。
Acta Biomater. 2016 Dec;46:177-190. doi: 10.1016/j.actbio.2016.09.010. Epub 2016 Sep 9.
6
Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy.葡萄糖响应介孔硅纳米颗粒用于生成过氧化氢以实现协同癌症饥饿和化学疗法。
Int J Nanomedicine. 2019 Apr 2;14:2233-2251. doi: 10.2147/IJN.S195900. eCollection 2019.
7
Openwork@Dendritic Mesoporous Silica Nanoparticles for Lactate Depletion and Tumor Microenvironment Regulation.介孔树枝状二氧化硅纳米载体用于乳酸耗竭和肿瘤微环境调控。
Angew Chem Int Ed Engl. 2020 Dec 1;59(49):22054-22062. doi: 10.1002/anie.202001469. Epub 2020 Oct 7.
8
HS-Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders.HS 动力纳米马达通过诱导铁死亡和乳酸-丙酮酸轴紊乱实现肿瘤的主动治疗。
ACS Biomater Sci Eng. 2024 Jun 10;10(6):3994-4008. doi: 10.1021/acsbiomaterials.3c01665. Epub 2024 May 12.
9
Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.金封介孔硅纳米粒子作为一种优异的酶响应型纳米载体用于控制阿霉素的递送。
J Drug Target. 2019 Dec;27(10):1084-1093. doi: 10.1080/1061186X.2019.1599379. Epub 2019 Apr 23.
10
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications.纳米载体对葡萄糖代谢的重编程以改善癌症免疫治疗:最新进展与应用
Int J Nanomedicine. 2025 Apr 5;20:4201-4234. doi: 10.2147/IJN.S513207. eCollection 2025.

引用本文的文献

1
Applications of Tailored Mesoporous Silicate Nanomaterials in Regenerative Medicine and Theranostics.定制介孔硅酸盐纳米材料在再生医学和诊疗学中的应用。
Int J Mol Sci. 2025 Aug 16;26(16):7918. doi: 10.3390/ijms26167918.
2
Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics.基于纳米颗粒的癌症治疗中抗耐药性递送策略
Cancers (Basel). 2025 Aug 11;17(16):2628. doi: 10.3390/cancers17162628.
3
Multidimensional characteristics of the tumor microenviron-ment and advances in therapeutic intervention strategies.

本文引用的文献

1
Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.可注射两性离子物理水凝胶,具有增强的化学动力学治疗和肿瘤微环境重塑特性,用于协同抗癌治疗。
ACS Nano. 2023 Dec 26;17(24):24883-24900. doi: 10.1021/acsnano.3c05898. Epub 2023 Oct 26.
2
Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.添加脂质体阿霉素增强了放射/αPD1 治疗诱导的远隔效应,这取决于肿瘤细胞线粒体 DNA 和 cGAS/STING。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2022-006235.
3
肿瘤微环境的多维特征及治疗干预策略的进展
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 16:1-11. doi: 10.3724/zdxbyxb-2025-0090.
Peroxymonosulfate Activation on Synergistically Enhanced Single-Atom Co/Co@C for Boosted Chemiluminescence of Tris(bipyridine) Ruthenium(II) Derivative.
过一硫酸盐在协同增强的单原子 Co/Co@C 上的活化用于增强三(联吡啶)钌(II)衍生物的化学发光。
Anal Chem. 2022 May 10;94(18):6866-6873. doi: 10.1021/acs.analchem.2c00881. Epub 2022 Apr 29.
4
pH-Responsive Nanocarriers in Cancer Therapy.癌症治疗中的pH响应性纳米载体
Polymers (Basel). 2022 Feb 26;14(5):936. doi: 10.3390/polym14050936.
5
Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer.颗粒酶B的临床前PET成像显示,在三阴性乳腺癌中,紫杉醇与免疫检查点抑制联合使用后免疫反应得到增强。
Pharmaceutics. 2022 Feb 18;14(2):440. doi: 10.3390/pharmaceutics14020440.
6
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
7
Targeted drug delivery strategies for precision medicines.精准药物的靶向给药策略。
Nat Rev Mater. 2021 Apr;6(4):351-370. doi: 10.1038/s41578-020-00269-6. Epub 2021 Feb 2.
8
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.淋巴细胞激活基因3蛋白在鼻咽癌中的表达与程序性细胞死亡蛋白1、程序性细胞死亡配体1及肿瘤浸润淋巴细胞相关。
Cancer Cell Int. 2021 Aug 28;21(1):458. doi: 10.1186/s12935-021-02162-w.
9
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer.MYC 通过转录上调三阴性乳腺癌中的 DNMT1 来抑制 STING 依赖性先天免疫。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002528.
10
Integrated analysis of multimodal single-cell data.多模态单细胞数据的综合分析。
Cell. 2021 Jun 24;184(13):3573-3587.e29. doi: 10.1016/j.cell.2021.04.048. Epub 2021 May 31.